首页> 美国卫生研究院文献>Netherlands Heart Journal >Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure Registry

【2h】

Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure Registry

机译：阿托伐他汀治疗可改善具有收缩功能障碍的慢性心力衰竭的预后：Daunia心力衰竭注册中心的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundFew works have evaluated the effect of statins on left ventricular dysfunction in patients with chronic heart failure (CHF), by using tissue Doppler imaging (TDI). We therefore aimed to investigate whether atorvastatin treatment may influence prognosis and myocardial performance evaluated by TDI in subjects with CHF.

机译：背景很少有研究通过使用组织多普勒成像（TDI）来评估他汀类药物对慢性心力衰竭（CHF）患者左心室功能障碍的影响。因此，我们旨在调查阿托伐他汀治疗是否会影响TDI对CHF患者的预后和心肌功能。

著录项

期刊名称 Netherlands Heart Journal
作者
M. Correale; A. Totaro; T. Passero; S. Abruzzese; F. Musaico; A. Ferraretti; R. Ieva; M. Di Biase; N. D. Brunetti;
展开▼
作者单位

展开▼
年(卷),期 2013(21),9
年度 2013
页码 408–416
总页数 9
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Chronic heart failure Atorvastatin Echocardiography Tissue Doppler imaging;

机译：慢性心力衰竭;阿托伐他汀;超声心动图;组织多普勒成像;

相似文献

外文文献
中文文献
专利

1. Lower cardiovascular mortality with atorvastatin and rosuvastatin vs simvastatin: Data from "moderate-intensity" statin users in an observational registry on chronic heart failure (Daunia Heart Failure Registry) [J] . Brunetti Natale Daniele, Correale Michele, Totaro Antonio, International Journal of Cardiology . 2015,第Null期

机译：阿托伐他汀和瑞舒伐他汀与辛伐他汀相比可降低心血管疾病的死亡率：“中等强度”他汀类药物使用者在慢性心力衰竭观察性注册表中的数据（Daunia心力衰竭注册表）
2. Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry [J] . Anna Maria Fanigliulo, Anna Rita Russo, Antonio Totaro, Clinics . 2011,第5期

机译：在慢性缺血性心力衰竭患者中，他汀类药物疗法可抑制炎症激活，改善组织多普勒成像评估的预后和左心室功能：Daunia心力衰竭注册中心的结果
3. Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry [J] . Michele Correale, Adriana Mallardi, Pietro Mazzeo, IJC Heart & Vasculature . 2020,第1期

机译：Sacubitril / Valsartan在慢性心力衰竭患者的真实寿命中提高了右心室功能：Daunia心力衰竭登记处
4. A Novel Ultrapotent Poly (ADP-ribose) Polymerase Inhibitor Improves Cardiac and Endothelial Dysfunction in Rat Model of Chronic Heart Failure [C] . P. Pacher, L. Liaudct, J.G. Mabley, International Congress on Coronary Artery Disease . 2003

机译：一种新型Ultrapotent Poly（ADP-核糖）聚合酶抑制剂改善了慢性心力衰竭大鼠模型中的心脏和内皮功能障碍
5. Adiponectin: Potential therapeutic target for the treatment of muscle wasting in chronic heart failure: In vitro exploration. [D] . Sente, Tahnee. 2016

机译：脂联素：治疗慢性心力衰竭的肌肉萎缩的潜在治疗靶标：体外研究。
6. Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry [O] . Michele Correale, Natale Daniele Brunetti, Antonio Totaro, 2011

机译：在慢性缺血性心力衰竭患者中他汀类药物治疗可钝化炎症激活并改善预后和左心室功能（通过组织多普勒成像评估）：Daunia心力衰竭注册中心的结果
7. Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure Registry [O] . M. Correale, A. Totaro, T. Passero, 2013

机译：阿托伐他汀治疗可改善具有收缩功能障碍的慢性心力衰竭的预后：Daunia心力衰竭注册中心的结果
8. Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysfunction. Clinical Practice Guideline No. 11; Heart Failure: Management of Patients with Left-Ventricular Systolic Dysfunction. Quick Reference Guide for Clinicians No. 11; Living with Heart Disease: Is It Heart Failure. Patient and Family Guide [R] . 1994

机译：心力衰竭：左心室收缩功能障碍患者的评估和护理。临床实践指南第11号;心力衰竭：左心室收缩功能障碍患者的治疗。临床医生快速参考指南第11号;与心脏病共存：是心衰吗？患者和家庭指南

Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure Registry

摘要

著录项

相似文献

相关主题

期刊订阅